vactosertib: Clinical Trials

9 trials of vactosertib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting, 1 suspended, 1 unknown. 9 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 6, Recruiting 1, Suspended 1, Unknown 1
Phase 24Completed 3, Recruiting 1

Follow vactosertib: new trials by email Literature Review of vactosertib trials Research Report on vactosertib

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
Vactosertib - Osteosarcoma
Phase 1 / Phase 2RecruitingMedPacto, Inc.782023-05-012026-10-07
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Vactosertib, Fludarabine Phosphate, Cyclophosphamide - Colorectal Cancer, Hematologic Malignancy
Phase 1SuspendedDavid Wald122022-09-092026-07-14
Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.
Vactosertib - Pancreas Cancer
Phase 1UnknownSamsung Medical Center242021-04-192022-06-15
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
vactosertib/imatinib combination - Desmoid Tumor
Phase 1 / Phase 2CompletedHyo Song Kim242019-04-152024-05-13
Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer
TEW-7197 - Metastatic Colorectal Cancer, Gastric Cancer
Phase 1 / Phase 2CompletedMedPacto, Inc.1202018-12-202025-03-25
TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer
TEW-7197 - Metastatic Gastric Cancer
Phase 1 / Phase 2CompletedMedPacto, Inc.622018-08-152024-12-09
Effect of Food on the Pharmacokinetics of TEW-7197 in Healthy Subjects
TEW-7197 - Healthy Volunteers
Phase 1CompletedMedPacto, Inc.162018-08-082020-04-14
Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma
Vactosertib, Pomalidomide - Multiple Myeloma
Phase 1CompletedKoen van Besien182017-07-212024-05-24
First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors
TEW-7197 - Advanced Stage Solid Tumors
Phase 1CompletedMedPacto, Inc.352014-07-292019-05-09

Conditions studied

Stomach Neoplasms (3)  ·  Colorectal Neoplasms (2)  ·  Multiple Myeloma (2)  ·  Neoplasm Metastasis (2)  ·  Camurati-Engelmann Syndrome (1)  ·  Desmoid Tumors (1)  ·  Esophageal Neoplasms (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Keratoacanthoma familial (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Myelodysplastic Syndromes (1)

Sponsors

MedPacto, Inc. (5)  ·  David Wald (1)  ·  Hyo Song Kim (1)  ·  Koen van Besien (1)  ·  Samsung Medical Center (1)

Countries

South Korea (6)  ·  United States (4)

Top investigators

Sunjin Hwang, MD (2)  ·  Benjamin Tomlinson, MD (1)  ·  Ilho Ha, PhD (1)  ·  Koen van Besien, MD, PhD (1)  ·  Minkyu Heo (1)

Results publications

PMID 39191755